Insider · CIK 0001874571
Maher Masoud
ceopresidentofficerdirector
Files at MXCT (MAXCYTE, INC.). First filing Aug 13, 2025, latest Aug 13, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$103k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MXCT: MAXCYTE, INC.
MXCTOct 9, 2026 · close 1.01
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 78Notable | MAXCYTE, INC. | $103k 75,000 shares | +75% | +9% from low-73% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | MXCT MAXCYTE, INC. | AGrant or award Common Stock | +300,000 | $0.00 | $0 | 475,000 | Mar 31, 2026 |
| Mar 27, 2026 | MXCT MAXCYTE, INC. | AGrant or award Employee Stock Option (right to buy)derivative | +600,000 | $0.00 | $0 | 600,000 | Mar 31, 2026 |
| Aug 13, 2025 | MXCT MAXCYTE, INC. | POpen-market purchase Common Stock | +75,000 | $1.37 | $103k | 175,000 | Aug 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.